Pyridam Farma’s loss worsened to IDR 214.2 billion in 9M 2024
04 Nov 2024 06:04
PT Pyridam Farma Tbk (PYFA), a pharmaceutical company, booked net loss of IDR 214.2 billion in the first nine months (9M) 2024.
PYFA subsidiary secures US$ 15 million loan from HSBC
19 Jul 2024 09:51
One of the subsidiaries of PT Pyridam Farma Tbk (PYFA), namely Pyfa Health Singapore Pte. Ltd. (Pyfa Singapore), has obtained a credit facility worth US$ 15 million or around IDR 242.6 billion.
Pyridam Farma eyes IDR 400 billion through bonds’ issuance
26 Jan 2024 09:26
PT Pyridam Farma Tbk (PYFA), a pharmaceutical company under Rejuve Global Investment, will issue its Shelf-Registration Bonds I of PYFA Phase III Year 2024, with a total principal of IDR 400 billion.
PYFA granted approval from shareholders to offer 16 billion shares in rights issue
09 Jan 2024 09:42
PT Pyridam Farma Tbk (PYFA), a pharmaceutical company operating since 1997, has managed to obtained approval during the Extraordinary General Meeting of Shareholders regarding the rights issue.